Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®.
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
CSF Metabolite Analysis May Offer Sensitive Biomarkers for MS
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.
Biogen Idec and Genentech announce restructuring of anti-CD20 collaboration agreement
Episode 57 with Dr. Timothy Vollmer, on the early phase 3 ocrelizumab results and implications
MS Research Roundup: July 17, 2014
Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Episode 36 with Dr. Jenny Ting on the inflammasome
Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Petite but Potent
Episode 60 with Dr. Timothy Vollmer on early, highly effective treatment
Safety Study of Combination Therapy with Intramuscular Avonex and Oral CellCept in Patients with Multiple Sclerosis
MS Research Roundup: May 16, 2014
An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.
IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity.
Gender-specific expression of beta1 integrin of VLA-4 in myelin basic protein-primed T cells: implications for gender bias in multiple sclerosis.
ACTRIMS-ECTRIMS 2014 -- Day 2, morning
Demyelination and Remyelination: From Mechanism to Therapy
Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
Episode 46 with Dr. Hans Lassmann on biomarkers in NMO and MS
Episode 48 with Dr. Bruce Cree on the EPIC, CLIMB, and SUMMIT clinical studies
BIIB033 single ascending dose study in healthy volunteer subjects

Pages